相关实验视频

Updated: Jun 4, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

236

非亲和平台用于处理旋进入孔双特异抗体.

Xiaoyang Wang1, Min Li1, Mengting Li1

  • 1Shanghai AsymBio Biotechnology Co., Ltd, Building 8, No.12, Lane 855, Jinzheng Road, Jinshan Industrial Park, Shanghai, China.

Bioresources and bioprocessing
|December 18, 2024
PubMed
概括

这项研究引入了一种对双特异抗体的新,简化净化方法,实现高纯度和回收. 非蛋白质A平台为生物治疗开发提供了有竞争力的替代方案.

关键词:
双特异性抗体 双特异性抗体副产品 副产品 副产品这种类型的同类基因是同类基因.非蛋白质A净化过程

更多相关视频

High-throughput Protein Expression Generator Using a Microfluidic Platform09:26

High-throughput Protein Expression Generator Using a Microfluidic Platform

Published on: August 23, 2012

11.7K
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

20.7K

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K